To evaluate the usefulness of cone beam computed tomography (CT)based parenchymal blood volume (PBV) mapping for the detection of marginal recurrence or residual hepatocellular carcinoma, after transcatheter arterial chemoembolization (TACE), and to compare it with multiphase dynamic CT (MDCT). Materials and Methods: From March 2015 to October 2016, 26 patients with 49 iodized nodules who underwent TACE and a pre-interventional MDCT scan were enrolled in our study. We evaluated the diagnostic efficacies of PBV mapping using cone beam CT and MDCT in the detection of marginal recurrences or viable tumors. Results: The sensitivity, specificity, positive predictive value, and negative predictive value (NPV) of PBV mapping and MDCT were 100%, 96.7%, 94.7%, and 100%, and 77.9%, 93.5%, 87.5%, and 87.8%, respectively. The overall sensitivity for identifying local marginal recurrence was higher for PBV mapping than for MDCT (p < 0.005). The performances of PBV mapping and MDCT in the diagnosis of local marginal recurrence were significantly different (p = 0.037, McNemar test). Conclusion: Compared with MDCT, PBV mapping can significantly increase the detection of marginal recurrence or residual tumor after TACE because it is free of beam-hardening artifact. PBV mapping should be considered as a feasible modalityrelated tool for patients who have undergone chemoembolization. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Transcatheter arterial chemoembolization (TACE) is currently one of the most widely performed methodologies for curative and palliative treatment of hepatic malignancies (1) (2) (3) .
Although conventional TACE has been shown to be an efficient therapeutic modality and has led to improved survival rates, it remains unsatisfactory due to the high recurrence rate (4, 5) . Therefore, the early detection of viable or recurrent tumor after chemoembolization is necessary to improve the long term out-comes and patient's prognosis (4, 6) .
Several imaging modalities have been used for follow-up after chemoembolization, including computed tomography (CT), contrast-enhanced ultrasonography, and magnetic resonance imaging (MRI); these have been compared for their utility in evaluation of the therapeutic effects and detection of recurrences (5, 7) . Recently, hepatocyte-specific MR contrast agents such as gadoxetic acid-enhanced MRI and the inclusion of diffusionweighted imaging have made it possible to diagnose even small hepatocellular carcinomas (HCCs) (8) . Although considered the optimal imaging modality because it has higher sensitivity and specificity than CT, CT still remains the "workhorse, " because of its lower cost and higher availability (7, 9) .
However, CT has problem with the interpretation of local marginal recurrences after chemoembolization, because of beam hardening artifact due to iodized oil (9) .
Recently, parenchymal blood volume (PBV) mapping using cone beam CT was introduced into the angiography suite. Cone beam CT can generate a three-dimensional data set, real time fluoroscopy, digital subtraction angiography (DSA), and tomographic images, and can achieve superior spatial resolution compared to conventional CT (10, 11) . PBV mapping using cone beam CT provides information on tumor angiogenesis and allows functional analysis with the results expressed in color and free from beam hardening artifacts; this can be advantageous for the detection of marginal recurrence after TACE (1, 5) .
Thus, the purpose of this study was to evaluate the feasibility of PBV mapping using cone beam CT as a follow up modality after TACE, and to compare it with multiphase dynamic CT (MDCT) in the detection of local marginal recurrence.
MaTeRIals aND MeThODs

Patients
This retrospective cohort study was approved by our Institutional Review Board (EMC 2018-06-008). We included 31 patients who had undergone TACE between March 2015 and October 2016. The inclusion criteria were 1) at least 18 years-of-age, 2) an interval between TACE procedures exceeding 1 month, 3) an interval between the pre-interventional follow-up CT and TACE of less than 1 month, and 4) received TACE in combination with pre interventional cone beam CT with PBV mapping.
We excluded patients, who had no previous TACE procedures (n = 1), received other anticancer treatment, including drug-eluted-microspheres TACE (DEM-TACE) (n = 1) and failed to obtain PBV mapping due to motion artifact (n = 3).
Finally, 26 patients with 49 iodized nodules were included in this study.
The baseline characteristics of the 26 patients are presented in Table 1 . All patients had preserved underlying liver function (Child-Pugh class A diseases). The mean interval between the pre-interventional follow-up CT and chemoembolization was 19 days (range, 1-30 days).
Multidetector CT
All patients underwent multiphasic CT before TACE. The CT We followed a previously described post-processing work flow (12) . The mask and fill run were reconstructed and subtracted, with motion between the two runs being corrected by a non-rigid registration algorithm. The value of the arterial input function was calculated from an automated histogram analysis of the vessel. The arterial input value was then applied as a scaling factor. In a final step, a smoothing filter was applied to re- were used for embolization, if required. Finally, completion angiography from the common hepatic artery was performed.
Data Analysis
The CT images were interpreted independently by two hepatobiliary radiologists with more than 5 years of experience in ab- 
ResUlTs
Of the two modalities, PBV mapping had higher sensitivity, specificity, and positive and negative predictive values than CT for the detection of marginal recurrence of HCC. The sensitivi-ty and negative predictive value of PBV mapping were 100%.
Sensitivity showed statistically significant differences between the two modalities (p < 0.005) ( Table 2 ).
In the 4 tumors with incorrect negative MDCT results, the PBV mapping accurately depicted the tumors (Table 3, Figs. 1-3). The McNemar's test showed a statistically significant difference for detection of marginal recurrence between the two modalities (p = 0.037).
One tumor identified on PBV mapping showed no enhancement on arterial phase on MDCT and no lipiodol uptake on TACE. This lesion remained untreated but at 6 months, lesion showed strong arterial enhancement with delayed washout and increased in size on MDCT. And proved to be a recurrent tumor on TACE (Fig. 4 ). 
DIsCUssION
In this study, PBV mapping using cone beam CT was successfully used to distinguish marginal recurrences after TACE. It was also shown to be more successful in the diagnosis of local marginal recurrence than MDCT (p = 0.037), with detection of some newly developed HCCs that were not apparent on CT.
PBV mapping also showed higher sensitivity, specificity, and positive and negative predictive values. We also showed statistically significant differences in sensitivity and diagnostic accuracy between the two modalities.
One of the important features of HCC is an increase in arterial vascularization (13) . CT and MRI may be inadequate for detecting such changes in tumor vascularity (14) , and CT has limitations due to beam hardening artifacts. Perfusion CT provides acceptable image quality and has been reported as being a useful tool for the assessment of liver tumor vascularity (15) and the monitoring and prediction of treatment responses to early antiangiogenic treatments (16, 17) .
Blood volume imaging with cone beam CT can also display similar features to perfusion CT, and has been shown to correlate very highly with it (18 
